Skinvisible, Inc.
SKVI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $6 | $6 | $4 | $3 |
| Enterprise Value | $7 | $7 | $4 | $4 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | 0% | -92.8% | -57.9% | – |
| Gross Profit | -$0 | $0 | $0 | $1 |
| % Margin | -2.2% | 100% | 98.3% | 99.5% |
| EBITDA | $0 | -$0 | -$0 | $0 |
| % Margin | 621.1% | -2,382.6% | -15.5% | 31.1% |
| Net Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | -2,828.3% | -11,912.2% | -791.8% | -344.5% |
| EPS Diluted | -0.11 | -0.52 | -0.49 | -0.5 |
| % Growth | 78.8% | -6.1% | 2% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |